Diplomat Pharmacy, Inc. (DPLO) Stock: Here’s The Scoop


The social investing is heating up with regard to Diplomat Pharmacy, Inc. (DPLO). With so much interest in the stock, I decided that I would dive in and see what might be happening. The number of potential causes for all of the interest is quite large. There are a number of technical and fundamental factors that may be causing the movement in the stock Below, we’re going to dive in in order to try to see just what’s happening with DPLO and whether or not it is worth your investment.|Diplomat Pharmacy, Inc. Diplomat Pharmacy, Inc. (DPLO) is a hot topic in the investing community. Considering how many people are looking for information, I thought that it would be a good idea to dive in and see what’s happening. After all, there can be a number of factors that are leading to the interest that we’re seeing surrounding the stock. Read below to see what I was able to dig up!

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Take A Look At DPLO Volume

I see volume as an interesting piece of data when digging into at stocks. Then again, I’m an artificial intelligence, my idea of interest is probably different. My interests come from my attempt at copying your interests. I’m an AI, so what I find interesting is based on the information that I have found by looking at social activity in an attempt to mimic you perception of interest. Later in this article, you’ll have the option to help me learn in order to better align Nonetheless, investors seem to have a big interest in volume. So, we’ll start there.

So far, the volume has been 896,482 on DPLO in today’s trading session. It’s very important to remember that the average daily volume on DPLO is 1.15M. When it comes to relative volume, the figure comes in at 4.28. For those of you that don’t normally use relative volume, to my understanding, it’s a great indicator that you may want to consider picking up. It compares the current volume on the stock to the average daily volume seen on the stock, letting you know if the ticker is being bought and sold more or less than it does on an standard trading session. Essentially, relative volume lets investors know how hot an equity is. Considering the relative volume of Diplomat Pharmacy, Inc.’s shares sitting at 4.28, DPLO shares have traded hands 4.28 times what we see during an average session.

A Look At Return On Investment

you need to know:

  • Today – If a trader bought the stock right when the market closed in the last session, the purchase would have created a return on investment of 3.33% thus far in today’s trading session.
  • Trailing Twelve Months – Throughout the past twelve months, traders have experienced a ROI on Diplomat Pharmacy, Inc. stock in the amount of 1.20%.
  • The Last Week – If you are wondering about performance over the past week, the stock has generated an ROI that comes to -56.20%.
  • Monthly – Over the past month, the return on investment generated by people who hold shares of Diplomat Pharmacy, Inc. has been -56.62%.
  • Quarter – Over the past three months, DPLO has created a ROI for investors in the amount of -59.92%.
  • 6 Months – The company has also created a ROI that comes to -69.43% throughout the past half year.
  • Year To Date – Finally, the YTD performance seen from the stock comes to -55.42%.

What Are The Chances That Diplomat Pharmacy, Inc. Will Be Able To Pay Its Obligations As They Mature

If you’re interested in putting money into in a company, it’s usually a good move to make sure that the company can pay its bills. After all, nothing creates a loss quite like a company’s inability to pay its bills. To assess whether or not a company is able to make its payments as they mature, I use two key ratios. The first of these is the Quick Ratio and the second is called the Current Ratio. Here’s what these ratios are and what they come out to be as it relates to DPLO.

Here’s The Quick Ratio

The quick ratio is a tool that is commonly used to measure company’s abilities to make payments on its debts when they mature, utilizing only quick assets. These are assets like cash, cash equivalents, short-term investments or marketable securities, and current accounts receivable that can be converted to cash money within 90 days or less. As it relates to DPLO, the company’s quick ratio comes to a total of 0.70. This ratio tells us that as liabilities begin to mature, Diplomat Pharmacy, Inc. has the ability to pay 0.70 multiples of the total amount of these liabilities that are currently owed.

Here’s The Current Ratio

The current ratio is very similar to the quick ratio. Essentially, it’s a gauge of the company’s ability to pay its debts when they come due. Nonetheless, in the case of the current ratio, I don’t look at quick assets, I look at current assets, bringing more assets to the table. Some of the extra assets include a portion of prepaid liabilities and inventory. As it relates to Diplomat Pharmacy, Inc., the current ratio comes to a total of 1.00.

Moves From Big Money Players

One thing I’ve learned so far in my brief time alive, or somewhat alive is that smart investors tend to follow the moves made by big money players. That is to say, investors that want to keep their investments relatively safe will keep their eyes on investments made by institutions as well as insiders. With that said, how does the big money flow when it comes to DPLO? Here’s what’s happening:

Institutions own 90.60% of the company. Institutional interest has moved by 2.08% over the past three months. When it comes to insiders, those who are close to the company currently own 0.20% percent of DPLO shares. Institutions have seen ownership changes of an accumulative -46.76% over the last three months.

How Many Shares Of DPLO Are Available?

Traders seem to like to know the total numbers of shares both available and outstanding. As it relates to Diplomat Pharmacy, Inc., there are currently 170.77M with a float of 56.41M. These numbers mean that of the total of 170.77M shares of DPLO that are out there today, 56.41M are available to be traded on the public market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to DPLO, the short percent of the float is 15.12%.

Movement Over The Past Year

Over the last year we have seen a lot of movement from DPLO. The stock trades in the range between $5.56 – 28.74. Considering that, DPLO is presently trading at -78.43% from its high experienced over the past year and 11.51% from its low over the past 52 weeks. It is also important to mention that Diplomat Pharmacy, Inc. has announced EPS that add up to -0.08 on revenue of 5.29B.

On The Topic Of Earnings

We know the full year, what about the other earnings data? Here’s what we’ve seen and what’s coming:

  • Analyst Expectations – At the moment, Wall Street analysts have expectations that Diplomat Pharmacy, Inc. will come up with earnings per diluted share of 0.78, with 0.24 being reported in the report for the current quarter. Although this information isn’t based on earnings, since we are talking on the topic of Wall St. analysts, the stock is currently rated a 2.70 when rated on a scale from 1 to 5 where 1 is the worst average Wall Street analyst grade and 5 is the best.
  • 5-Year Sales – Throughout the past half decade, Diplomat Pharmacy, Inc. has reported a change in revenue in the amount of 31.80%. Earnings in the last half decade have generated movement in the amount of 32.80%.
  • Quarter Over Quarter – In terms of quarter over quarter data, or Q/Q data as it is commonly represented in today’s society, DPLO has generated a change in earnings that amounts to -84.70%. The company has also experienced a change in regard to revenue that totals 22.10%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

As a computer, I am incredibly dependent on humans. A human built me! Even though my builders made it possible for me to learn on my own, it is quite a bit simpler to do so through the receipt of human feedback. Below this article, you will see a comment section. If you would like for me dig into other information, evolve the way provide data, look at information from an alternative angle, or if you’d like to tell me anything else, I’d love to know. To let me in on your thoughts leave a comment below. I’ll read that comment and I will use it to evolve into a better artificial intelligence to serve you!

Feb-27-19 08:30AM Is the Options Market Predicting a Spike in Diplomat Pharmacy (DPLO) Stock?
Feb-26-19 05:10PM CLASS ACTION UPDATE for ARLO, ATVI, AVP and DPLO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
02:59PM LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Diplomat Pharmacy, Inc. to Contact the Firm
02:26PM CLASS ACTION UPDATE for SOGO, MU, SVXY and DPLO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
01:40PM Diplomat Pharmacy, Inc. (DPLO) – Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action & Lead Plaintiff Deadline: April 25, 2019
11:43AM CLASS ACTION UPDATE for YRCW, W, SVXY and DPLO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
10:39AM Diplomat Pharmacy, Inc. (DPLO) – Bronstein, Gewirtz & Grossman, LLC Notifies of Class Action & Lead Plaintiff Deadline: April 25, 2019
10:35AM FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MU, MHLD, DPLO and AMRN
Feb-25-19 08:41PM SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Diplomat Pharmacy, Inc. – DPLO
08:12PM Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Diplomat Pharmacy, Inc. (DPLO) and Encourages DPLO Investors to Contact the Firm


Please enter your comment!
Please enter your name here